Clinical Trial Update: 480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV) [Phase 2]

View source ↗

Summary

Phase 2b study of Locteron plus ribavirin for chronic hepatitis C completed; results are not detailed in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Locteron
• Ribavirin (ribavirin)

Snippet

Sponsor: Biolex Therapeutics, Inc. | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED